AzTrials
AzTrials

Chronic StrokePhase 2ANIMATORNCT06538506

ANIMATOR - RehUP BCI Controlled Robotic Therapy vs. an Attention-based Control

A Phase 2 study testing RehUp BCI Intervention in people with Chronic Stroke, run by University of Calgary at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

ANIMATOR aims to examine how BCI therapy vs. attention based control therapy can be used to treat people in the chronic phase of stroke with moderate to severe upper extremity impairment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Stroke
What is being tested?
RehUp BCI Intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCanada
Study dates
Aug 2024to Mar 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Stroke survivors, ≥ 6 months post-stroke with severe arm impairment.
  • 18 years of age of older
  • Adequate language skills to be able to follow instructions
  • FM-UE score 30 or less at study entry (i.e., severe arm impairment and would likely not use the stroke-affected arm in daily activities)
  • Modified Ashworth Score ≦ 2
  • Visual acuity 20/50 corrected (both eyes)

Who cannot join

  • Potential participants will be excluded if they do not meet the requirements above, or:
  • have neurologic history in addition to stroke (injury or disease), eg. TBI, MS, dementia
  • enrollment in concurrent interventional trial
  • major co-morbid illness making study completion unlikely
  • contraindication to MRI (such as pacemaker, pregnancy, etc).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sean P Dukelow, MD PhD FRCPC contact

(403)944-4050

robotlab@ucalgary.ca

Canada1 site
  • Foothills Hospital

    Calgary, Alberta, T2N2T9

Other trials in Canada

About this study

Official title: ANIMATOR - A Single-blind Randomized Controlled Trial of RehUP BCI Controlled Robotic Therapy vs. an Attention-based Control

ANIMATOR aims to examine how BCI therapy vs. attention based control therapy can be used to treat people in the chronic phase of stroke with moderate to severe upper extremity impairment. This interventional trial has two phases: Pilot (10 consecutive days of intervention) and a Randomized Phase (24 sessions over 8 weeks).

Read the detailed description

There is a large population of Canadians with chronic stroke and severely impaired upper limbs. Consultation with this population reveals individuals who are looking for treatment to improve their ability to move their arm and hand. The aim of the trial is to offer such a post-stroke neurorehabilitation solution using the RehUp brain computer interface (BCI). To do so, the investigators will harness neuroplastic mechanisms that form new connections in the brain helping the participant to move their arm and hand voluntarily outside of BCI and robotic support.

Given the potential for BCI facilitated post-stroke therapy to improve upper extremity function, the investigators will conduct a pilot trial and then a randomized controlled trial to compare the responses of the upper extremity in chronic stroke survivors to RehUp BCI controlled robotic device vs. an attention-based control comparator.

ANIMATOR is a phase 2, prospective, open label, randomized, controlled trial with blinded outcome assessment. Randomization will be centrally blocked and computerized. Participants will be randomized 1:1 BCI intervention or control.

In the Pilot phase, 10 participants will be enrolled and all allocated to the intervention arm.

In the Randomized Phase, Forty stroke survivors more than 6 months post-stroke with severe arm impairment will be recruited for this trial. Participants will complete 24 one-hour sessions (3x/wk for 8 weeks) of BCI robotic upper extremity therapy, or a control intervention. Potential participants will be identified by stroke physiatrists, neurologists and therapists working in clinics with individuals with stroke related impairment. They may also be identified through previous participation in research studies at one of the trial sites or through self-identification in response to community outreach by the investigators to local stroke recovery groups. Consent will be acquired prior to participating in the study. Participant will be screened using the Fugl-Meyer Upper Extremity (FM-UE), Modified Ashworth Scale (MAS), and Visual Acuity measures to meet inclusion criteria after they have consented to participate.

All groups will receive standard of care rehabilitation. Participants will not be blinded, but the assessor therapist will be. These therapists will complete a training session with the central site to ensure replicability between sites and assessors. Blinded assessors will never deliver either intervention in the trail.

The BCI intervention uses the VIBRAINT BCI robot. It allows participants to perform tasks in a virtual reality environment. In the VR,the participant is given a task to either focus on the motor goal (a target virtual object) or imagine motion of the paralyzed arm connected to this object while reaching to it or grasping it. Once the BCI recognizes cortical activity related to the assigned task, it sends a message to the robotic device to accomplish the desired motion, complemented by synchronous movement in Virtual Reality (VR) of the participant's avatar's arm. During the robotic-driven motion the participant imagines the movement as if it is being performed by them voluntarily. The participant will perform a series of tasks in VR focused on improving arm and hand function. These tasks will be scaled in difficulty and tailored to the participant's level of impairment. The goal is for the participant to complete as many repetitions as possible. A therapist will supervise these sessions to ensure the participant does not become too fatigued. The session will last 45 minutes.

The control intervention is completed with a therapist and focuses on three activities: passive range of motion exercises, motor imagery, and mirror therapy for 15 minutes each.

Conditions
Chronic Stroke
Being tested
RehUp BCI Intervention, Control Therapy
Keywords
Brain Computer Interface, Robotic Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RehUp BCI InterventionDevice

    Participants will be seated wearing a cap on their head containing surface electrodes connected to a computer/laptop. The laptop employs machine learning algorithms and uses the scalp electroencephalogram (EEG) signals from the scalp's surface to control a robotic arm which supports the patient's stroke-affected arm. The machine learning algorithms rapidly interpret EEG signals and adjust the outgoing movement commands to the robot based on an individual's responses to stimuli. The participant will be wearing a VR headset. The VR displays visual stimulus in time with the robotic arm. Based on information from the EEG, the participant is able to animate their robotic arm and receive visual task-based feedback in the VR.

  • Control TherapyOther

    The study therapist will focus on 3 activities (~15 minutes each/session): passive range of motion exercises, motor imagery, and mirror therapy. These activities were chosen as they are all passive activities that are commonly used in a patient with severe impairment of the post-stroke arm and hand. Each session will last ~1hour including set up and switching between activities.

Study groups in NCT06538506
Study groupRoleWhat they receive
RehUp BCI interventionExperimentalThe BCI intervention will complete 24 one hour intervention sessions (3x/week for 8 weeks).
Receives: Device: RehUp BCI Intervention
Control TherapyActive comparatorParticipants randomly allocated to the control therapy arm will complete 24 one hour therapy sessions (3x/week for 8 weeks).
Receives: Other: Control Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Upper Extremity (FM-UE)

    Change in Fugl-Meyer Upper Extremity (FM-UE) from measurement at baseline. The FM-UE is the most widely used outcome measure for upper limb stroke recovery studies.

    The FM-UE is scored on a scale from 0 to 66, where 66 points indicates unimpaired motor function.

    Measured: Baseline, 4weeks, 8 weeks, 16 weeks

Secondary outcomes (4)
  1. Action Research Arm Test (ARAT)

    Change in Action Research Arm Test (ARAT) from measurement at baseline. The ARAT will provide complimentary data on limb impairment.

    The ARAT is scored on a scale from 0 to 57 points, where 57 points indicates unimpaired motor function.

    Measured: Baseline, 4 weeks, 8 weeks, 16 weeks

  2. Modified Ashworth Scale (MAS)

    Change in Modified Ashworth Scale (MAS) from measurement at baseline. The MAS is used to assess spasticity.

    The MAS is scored on a 6 point scale [0, 1, 1+, 2, 3, 4]. 0 indicates no increase in tone. 4 indicates the limb is rigid in flexion or extension.

    Measured: Baseline, 4 weeks, 8 weeks, 16 weeks

  3. Patient Health Questionnaire - Module 9 (PHQ-9)

    Change in Patient Health Questionnaire - Module 9 (PHQ-9) from measurement at baseline. The PHQ-9 is used to screen for depression.

    The PHQ-9 is a 10 question screening tool where nine of the ten items are scored on a scale from 0 to 3. The tenth item grades how difficult the first nine items make the participant's day-to-day life. A lower score indicates a lower likelihood and/or severity of depression.

    Measured: Baseline, 4 weeks, 8 weeks, 16 weeks

  4. EQ-5D (EuroQuol Measure of Health Status, Version 5D)

    Change in EQ-5D (EuroQuol Measure of Health Status, Version 5D) from measurement at baseline. The EQ-5D is used to measure quality of life.

    The EQ-5D scores fives areas of health on a scale of 1-5, where 1 indicates no problems and 5 indicates extreme problems.

    Measured: Baseline, 4 weeks, 8 weeks, 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study startAug 2024 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are assigned to one of two groups for the duration of the study (BCI therapy or standard physiotherapy employing active and passive range of motion exercises).
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06538506
Sponsor's protocol ID
ANIMATOR
Acronym
ANIMATOR
Status last verified
Aug 2024
First submitted
1 Aug 2024
Last updated
9 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No plan to make IPD available to other researchers.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing RehUp BCI Intervention in people with Chronic Stroke, run by University of Calgary at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mark A Piitz ((403)944-1085, robotlab@ucalgary.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Upper Extremity (FM-UE) (time frame: Baseline, 4weeks, 8 weeks, 16 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in